Companion Diagnostic Technologies Market is Expected to Hit $ 3.5 billion by 2020: Development Factors and Investment Analysis By Top Players
Helper Diagnosis (CD) is an in vitro diagnostic technique that provides information about the patient's response to a specific treatment. Companion diagnosis helps identify patients who can benefit from a particular treatment, resulting in better treatment outcomes and lower health care spending. CD can also help identify patient pools that are most responsive to treatment. Therefore, we exclude therapies that are not effective. It also reduces costs by protecting patients from side effects caused by ineffective therapy. As the incidence of cancer increases and the side effects of drugs and personalized therapies increase, research and development efforts are under way to focus on the development of targeted therapies.
The technological advances and discoveries of new biomarkers are also driving the growth of this market. However, coordinating co-diagnosis and therapeutic development is a challenge for this market. Nonetheless, significant investments have been made in the research and development of targeted therapies that require companion diagnostics due to increased cancer, cardiovascular disease, and central nervous system and which may be opportunities for growth in this market.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/135
The accompanying diagnostic diagnostics market is divided into oncology, cardiovascular, CNS, autoimmune & inflammation, virology and others. Currently, the vast majority of companion diagnostics are developed for cancer, so it is a major revenue generating segment in the entire CD display market. Companion diagnosis has been developed for breast cancer, lung cancer, colorectal cancer, stomach cancer and melanoma.
Companion diagnosis for breast cancer is the most common breast cancer incidence because of the increased incidence of breast cancer and the development of many companion diagnoses to detect HER / neu biomarkers for breast cancer. Currently, there is little or no accompanying diagnosis for cardiovascular disease, central nervous system conditions, inflammation and autoimmune diseases and viral diseases, and most of them are in the development stage. However, as more and more biomarkers are discovered, the development of new companion diagnostics will increase.
Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/135
The technology-specific companion diagnostic market is divided into immunohistochemistry and molecular diagnostics. Molecular diagnostics is the most preferred technology, and next-generation sequencing and real-time PCR are expected to drive growth in this market due to advances in these technologies.
The market is followed by North America and Europe due to significant improvements in medical awareness, significant investment in research and development, and an increase in cancer and other disease incidence in the region.
However, LAMEA is expected to increase at a significant rate due to the increased incidence of cancer in this region. There is also a growing awareness of medical care in the region. The use of companion diagnostics will therefore continue to increase.
The ten major companies dealing with companion diagnostics are profiled, such as Qiagen, Dako (Agilent Technologies), Roche, Abbott Laboratories, Inc., bioMerieux, Ventana Medical Systems, Myriad Genetics, Inc., Leica Microsystems, Resonance Health Ltd, . The key strategy most companies follow is working with pharmaceutical companies to develop companion diagnostics for pipeline drugs.
Access Full Summery @ https://www.alliedmarketresearch.com/companion-diagnostic-technologies-market
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostic Technologies Market is Expected to Hit $ 3.5 billion by 2020: Development Factors and Investment Analysis By Top Players here
News-ID: 1661400 • Views: 339
More Releases from Allied Market Research
Treasury and Risk Management Market Insights 2020: Top Factors That Are Leading …
The Treasury and Risk Management Market report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Management of large quantity of data in a centralized manner by
Service Integration and Management Market 2020: Technical Signs Point Rapid Grow …
The Objective of the “Global Service Integration and Management Market ” report is to depict the trends and upcoming for the Service Integration and Management Market industry over the forecast years. Service Integration and Management Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2027 mulling over 2019 as the base year of the
Wealth Management Platform Market 2020 Technical Signs Point Rapid Growth In Com …
The Objective of the “Global Wealth Management Platform Market ” report is to depict the trends and upcoming for the Wealth Management Platform Market industry over the forecast years. Wealth Management Platform Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2027 mulling over 2019 as the base year of the market study. Attentiveness
Deep Learning Market Size 2020: Innovation and Product Optimization With Dominat …
Allied Market Research published a new report, titled, " Deep Learning Market " The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Rising need
More Releases for Companion
Companion Diagnostics Market – Growth , Opportunities and Applications
Companion diagnostics are tests to understand which patient can be benefited from a certain drug or what dosage should be prescribed based upon patient’s clinical diagnosis, which provides evidence required for the successful and harmless use of an equivalent drug or biological product to treat the medical condition. These are medical instruments that support doctors to elect which treatment and dosage should be given to patients personalized to their necessity. Companion
A Smart Companion to your TV
Following HELLO’s very successful Kickstarter campaign (1339% funded), Solaborate is launching the new and improved HELLO 2 on Kickstarter, along with HELLO Touch TV, HELLO Creator Edition and 2 Gadget Extensions. A Smart Companion to your TV HELLO 2, like its predecessor, turns any TV into a video communication and collaboration device. HELLO 2 does everything users love about the original even better with Alexa support, home automation (Zigbee), and Android games,
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Farm & Companion Animal Health Market
Veterinary healthcare products include pharmaceuticals, nutrition (feed additives) and devices for both companion and livestock animals. Companion animals include pets such as dogs, cats and horses; although in recent years the market has expanded reasonably for avian pets, reptiles and exotic fish. The healthcare products have transformed the health and quality of life for millions of pets across the world. The greatest challenge of maintaining pets is seeking the keenness
Global Companion Diagnostics Market to Grow Globally
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.